Results 1 to 10 of about 29,426 (268)

Clinical applications of therapeutic phlebotomy

open access: yesJournal of Blood Medicine, 2016
Kyung Hee Kim,1 Ki Young Oh,2 1Department of Laboratory Medicine, Gachon University Gil Medical Center, Incheon, 2Department of Physical Medicine and Rehabilitation, Soonchunhyang University, Cheonan Hospital, Cheonan, South Korea Abstract: Phlebotomy is
Kim KH, Oh KY
doaj   +5 more sources

Patient harm associated with serial phlebotomy and blood waste in the intensive care unit: A retrospective cohort study.

open access: yesPLoS ONE, 2021
BackgroundIntensive care unit (ICU) patients are at high risk of anemia, and phlebotomy is a potentially modifiable source of blood loss. Our objective was to quantify daily phlebotomy volume for ICU patients, including blood discarded as waste during ...
Thomas Bodley   +7 more
doaj   +2 more sources

Effect of phlebotomy versus oral contraceptives containing cyproterone acetate on the clinical and biochemical parameters in women with polycystic ovary syndrome: a randomized controlled trial

open access: yesJournal of Ovarian Research, 2019
Background Reduction of the body iron stores can improve hyperandrogenemia and insulin resistance. This study aimed to compare clinical and para-clinical responses to the treatment of phlebotomy using oral contraceptive pills (OCs) containing cyproterone
Samira Behboudi-Gandevani   +4 more
doaj   +2 more sources

Occurrence and Recurrence of Hepatocellular Carcinoma Were Not Rare Events during Phlebotomy in Older Hepatitis C Virus-Infected Patients [PDF]

open access: goldCase Reports in Oncology, 2014
The use of phlebotomy is relatively common for ‘difficult-to-treat by antiviral therapies' hepatitis C virus (HCV)-infected patients and for certain patients having chronic liver diseases with an iron overload of the liver.
Tatsuo Kanda   +9 more
doaj   +2 more sources

Effects of Phlebotomy on Liver Enzymes and Histology of Patients with Nonalcoholic Fatty Liver Disease

open access: yesAdvanced Biomedical Research, 2017
Background: Nonalcoholic fatty liver disease (NAFLD), defined as excessive liver fat deposition and one of end-stage liver disease causes. Increased ferritin levels are associated with insulin resistance and a higher hepatic iron and fat content ...
Mahsa Khodadoostan   +5 more
doaj   +2 more sources

Personnel’s Experiences of Phlebotomy Practices after Participating in an Educational Intervention Programme [PDF]

open access: goldNursing Research and Practice, 2014
Background. Blood specimen collection is a common procedure in health care, and the results from specimen analysis have essential influence on clinical decisions.
Karin Bölenius   +2 more
doaj   +2 more sources

Outcome of phlebotomy for treating nonalcoholic fatty liver disease: A systematic review and meta-analysis

open access: yesThe Saudi Journal of Gastroenterology, 2016
Background/Aims: No medications have been approved for managing nonalcoholic fatty liver disease (NAFLD). Lifestyle intervention is the mainstay for its treatment.
Veeravich Jaruvongvanich   +3 more
doaj   +2 more sources

Testosterone therapy-induced erythrocytosis: can phlebotomy be justified? [PDF]

open access: yesEndocrine Connections
Erythrocytosis, or elevated hematocrit, is a common side effect of testosterone therapy (TTh) in male hypogonadism. Testosterone stimulates erythropoiesis through an initial rise in erythropoietin (EPO), the establishment of a new EPO/hemoglobin ‘set ...
Peter Bond   +2 more
doaj   +2 more sources

Incidence of Hepatocellular Carcinoma Reduced by Phlebotomy Treatment in Patients with Chronic Hepatitis C

open access: goldInternal medicine, 2015
OBJECTIVE To determine the impact of phlebotomy on the laboratory values and the incidence of hepatocellular carcinoma (HCC) in patients with hepatitis C. METHODS Study patients with chronic hepatitis C were treated with glycyrrhizin injection and oral
Kazushige Nirei   +4 more
openalex   +3 more sources

The Impact of Sira Vedha (Phlebotomy) at the Right Elbow Joint in the Treatment of Non-Alcoholic Fatty Liver Disease - A Research Report

open access: yesJournal of Pharmacy and Bioallied Sciences
Non-alcoholic fatty liver disease (NAFLD) affects 9%–53% of the Indian population. No Indian studies have examined Sira Vedha (phlebotomy) for NAFLD, although it has been studied for other conditions.
Gaurav Sawarkar, Punam Sawarkar
doaj   +2 more sources

Home - About - Disclaimer - Privacy